Literature DB >> 29279887

Regional Variation of Computed Tomographic Imaging in the United States and the Risk of Nephrectomy.

H Gilbert Welch1,2,3, Jonathan S Skinner1,4, Florian R Schroeck1,3,5,6, Weiping Zhou1, William C Black1,7.   

Abstract

Importance: While computed tomography (CT) represents a tremendous advance in diagnostic imaging, it also creates the problem of incidental detection-the identification of tumors unrelated to the clinical symptoms that initiate the test. Objective: To determine the geographic variation in the United States in CT imaging and the corresponding association with one of the most consequential sequelae of incidental detection: nephrectomy. Design, Setting, and Participants: This study is a cross-sectional analysis of age-, sex-, and race-adjusted Medicare data (January 2010-December 2014) from 306 hospital referral regions (HRRs) in the United States and includes information from 15 million fee-for-service Medicare beneficiaries age 65 to 85 years. Exposures: Regional CT risk (ie, the proportion of the population receiving either a chest or abdominal CT over 5 years). Main Outcomes and Measures: Five-year risk of nephrectomy (partial or total).
Results: Data from 15 million fee-for-service Medicare beneficiaries age 65 to 85 years were gathered and illustrate that 43% of Medicare beneficiaries age 65 to 85 years received either a chest or abdominal CT from January 2010 to December 2014. This risk varied across the HRRs, ranging from 31% in Santa Cruz, California, to 52% in Sun City, Arizona. Increased regional CT risk was associated with a higher nephrectomy risk (r = 0.38; 95% CI, 0.28-0.47), particularly among HRRs with more than 50 000 beneficiaries (r = 0.47; 95% CI, 0.31-0.61). After controlling for HRR adult smoking rates, imaging an additional 1000 beneficiaries was associated with 4 additional nephrectomies (95% CI, 3-5). Case-fatality rates for those who underwent nephrectomy were 2.1% at 30 days and 4.3% at 90 days. Conclusions and Relevance: Fee-for-service Medicare beneficiaries are commonly exposed to CT imaging. Those residing in high-scanning regions face a higher risk of nephrectomy, presumably reflecting the incidental detection of renal masses. Additional surgery should be considered one of the risks of excessive CT imaging.

Entities:  

Mesh:

Year:  2018        PMID: 29279887      PMCID: PMC5838611          DOI: 10.1001/jamainternmed.2017.7508

Source DB:  PubMed          Journal:  JAMA Intern Med        ISSN: 2168-6106            Impact factor:   21.873


  30 in total

Review 1.  Clinical practice. Small renal mass.

Authors:  Inderbir S Gill; Monish Aron; Debra A Gervais; Michael A S Jewett
Journal:  N Engl J Med       Date:  2010-02-18       Impact factor: 91.245

Review 2.  Computed tomography--an increasing source of radiation exposure.

Authors:  David J Brenner; Eric J Hall
Journal:  N Engl J Med       Date:  2007-11-29       Impact factor: 91.245

3.  The overuse of diagnostic imaging and the Choosing Wisely initiative.

Authors:  Vijay M Rao; David C Levin
Journal:  Ann Intern Med       Date:  2012-10-16       Impact factor: 25.391

4.  Easy way to learn standardization : direct and indirect methods.

Authors:  N N Naing
Journal:  Malays J Med Sci       Date:  2000-01

5.  Life Expectancy and Variation in Treatment for Early Stage Kidney Cancer.

Authors:  Timothy J Daskivich; Hung-Jui Tan; Mark S Litwin; Jim C Hu
Journal:  J Urol       Date:  2016-03-21       Impact factor: 7.450

6.  Addressing overutilization in medical imaging.

Authors:  William R Hendee; Gary J Becker; James P Borgstede; Jennifer Bosma; William J Casarella; Beth A Erickson; C Douglas Maynard; James H Thrall; Paul E Wallner
Journal:  Radiology       Date:  2010-08-24       Impact factor: 11.105

7.  Clear cell renal cell tumors: Not all that is "clear" is cancer.

Authors:  Sean R Williamson; Liang Cheng
Journal:  Urol Oncol       Date:  2016-03-14       Impact factor: 3.498

8.  Managing incidental findings on abdominal CT: white paper of the ACR incidental findings committee.

Authors:  Lincoln L Berland; Stuart G Silverman; Richard M Gore; William W Mayo-Smith; Alec J Megibow; Judy Yee; James A Brink; Mark E Baker; Michael P Federle; W Dennis Foley; Isaac R Francis; Brian R Herts; Gary M Israel; Glenn Krinsky; Joel F Platt; William P Shuman; Andrew J Taylor
Journal:  J Am Coll Radiol       Date:  2010-10       Impact factor: 5.532

Review 9.  EAU guidelines on renal cell carcinoma: 2014 update.

Authors:  Borje Ljungberg; Karim Bensalah; Steven Canfield; Saeed Dabestani; Fabian Hofmann; Milan Hora; Markus A Kuczyk; Thomas Lam; Lorenzo Marconi; Axel S Merseburger; Peter Mulders; Thomas Powles; Michael Staehler; Alessandro Volpe; Axel Bex
Journal:  Eur Urol       Date:  2015-01-21       Impact factor: 20.096

10.  Active surveillance of renal masses in elderly patients.

Authors:  Robert Abouassaly; Brian R Lane; Andrew C Novick
Journal:  J Urol       Date:  2008-06-11       Impact factor: 7.450

View more
  31 in total

1.  Trends in Renal-Cell Carcinoma Incidence and Mortality in the United States in the Last 2 Decades: A SEER-Based Study.

Authors:  Anas M Saad; Mohamed M Gad; Muneer J Al-Husseini; Inas A Ruhban; Mohamad Bassam Sonbol; Thai H Ho
Journal:  Clin Genitourin Cancer       Date:  2018-10-11       Impact factor: 2.872

2. 

Authors:  Harminder Singh; James A Dickinson; Guylène Thériault; Roland Grad; Stéphane Groulx; Brenda J Wilson; Olga Szafran; Neil R Bell
Journal:  Can Fam Physician       Date:  2018-09       Impact factor: 3.275

3.  Overdiagnosis: causes and consequences in primary health care.

Authors:  Harminder Singh; James A Dickinson; Guylène Thériault; Roland Grad; Stéphane Groulx; Brenda J Wilson; Olga Szafran; Neil R Bell
Journal:  Can Fam Physician       Date:  2018-09       Impact factor: 3.275

4.  Society of Abdominal Radiology disease-focused panel on renal cell carcinoma: update on past, current, and future goals.

Authors:  Matthew S Davenport; Hersh Chandarana; Nicole E Curci; Ankur Doshi; Samuel D Kaffenberger; Ivan Pedrosa; Erick M Remer; Nicola Schieda; Atul B Shinagare; Andrew D Smith; Zhen J Wang; Shane A Wells; Stuart G Silverman
Journal:  Abdom Radiol (NY)       Date:  2018-09

5.  Predicting biological behaviour of newly diagnosed renal masses: a possible role of cell proliferation biomarkers?

Authors:  Riccardo Mastroianni; Aldo Brassetti; Manuela Costantini; Giuseppe Simone
Journal:  Ann Transl Med       Date:  2019-07

Review 6.  The changing landscape of cancer in the USA - opportunities for advancing prevention and treatment.

Authors:  Farhad Islami; Rebecca L Siegel; Ahmedin Jemal
Journal:  Nat Rev Clin Oncol       Date:  2020-05-28       Impact factor: 66.675

Review 7.  Bosniak Classification of Cystic Renal Masses, Version 2019: An Update Proposal and Needs Assessment.

Authors:  Stuart G Silverman; Ivan Pedrosa; James H Ellis; Nicole M Hindman; Nicola Schieda; Andrew D Smith; Erick M Remer; Atul B Shinagare; Nicole E Curci; Steven S Raman; Shane A Wells; Samuel D Kaffenberger; Zhen J Wang; Hersh Chandarana; Matthew S Davenport
Journal:  Radiology       Date:  2019-06-18       Impact factor: 11.105

8.  KIM-1 as a Blood-Based Marker for Early Detection of Kidney Cancer: A Prospective Nested Case-Control Study.

Authors:  Ghislaine Scelo; David C Muller; Elio Riboli; Mattias Johansson; Amanda J Cross; Paolo Vineis; Konstantinos K Tsilidis; Paul Brennan; Heiner Boeing; Petra H M Peeters; Roel C H Vermeulen; Kim Overvad; H Bas Bueno-de-Mesquita; Gianluca Severi; Vittorio Perduca; Marina Kvaskoff; Antonia Trichopoulou; Carlo La Vecchia; Anna Karakatsani; Domenico Palli; Sabina Sieri; Salvatore Panico; Elisabete Weiderpass; Torkjel M Sandanger; Therese H Nøst; Antonio Agudo; J Ramón Quirós; Miguel Rodríguez-Barranco; Maria-Dolores Chirlaque; Timothy J Key; Prateek Khanna; Joseph V Bonventre; Venkata S Sabbisetti; Rupal S Bhatt
Journal:  Clin Cancer Res       Date:  2018-07-23       Impact factor: 12.531

Review 9.  Current Management of Small Renal Masses, Including Patient Selection, Renal Tumor Biopsy, Active Surveillance, and Thermal Ablation.

Authors:  Alejandro Sanchez; Adam S Feldman; A Ari Hakimi
Journal:  J Clin Oncol       Date:  2018-10-29       Impact factor: 44.544

10.  Metabolic imaging with hyperpolarized 13 C pyruvate magnetic resonance imaging in patients with renal tumors-Initial experience.

Authors:  Shuyu Tang; Maxwell V Meng; James B Slater; Jeremy W Gordon; Daniel B Vigneron; Bradley A Stohr; Peder E Z Larson; Zhen Jane Wang
Journal:  Cancer       Date:  2021-04-12       Impact factor: 6.860

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.